These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33387018)
41. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients. Hasparyk UG; Vigil FMB; Bartolomei VS; Nunes VM; Simões E Silva AC Curr Med Chem; 2022 Aug; 29(31):5230-5253. PubMed ID: 35306980 [TBL] [Abstract][Full Text] [Related]
42. Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities. Ewert A; Leifheit-Nestler M; Hohenfellner K; Büscher A; Kemper MJ; Oh J; Billing H; Thumfart J; Stangl G; Baur AC; Föller M; Feger M; Weber LT; Acham-Roschitz B; Arbeiter K; Tönshoff B; Zivicnjak M; Haffner D J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413117 [TBL] [Abstract][Full Text] [Related]
43. Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function . Nowak KL; Hung A; Ikizler TA; Farmer-Bailey H; Salas-Cruz N; Sarkar S; Hoofnagle A; You Z; Chonchol M Clin Nephrol; 2017 Sep; 88(9):132-143. PubMed ID: 28699886 [TBL] [Abstract][Full Text] [Related]
44. Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease. Stremke ER; Biruete A; Hill Gallant KM Curr Osteoporos Rep; 2020 Jun; 18(3):247-253. PubMed ID: 32240477 [TBL] [Abstract][Full Text] [Related]
45. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703 [TBL] [Abstract][Full Text] [Related]
47. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
48. Bone alkaline phosphatase in CKD-mineral bone disorder. Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575 [TBL] [Abstract][Full Text] [Related]
49. The role of activin: the other side of chronic kidney disease-mineral bone disorder? Cianciolo G; La Manna G; Capelli I; Gasperoni L; Galassi A; Ciceri P; Cozzolino M Nephrol Dial Transplant; 2021 May; 36(6):966-974. PubMed ID: 32940690 [TBL] [Abstract][Full Text] [Related]
50. International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps. Liabeuf S; McCullough K; Young EW; Pisoni R; Zee J; Reichel H; Pecoits-Filho R; Port FK; Stengel B; Csomor PA; Metzger M; Robinson B; Massy ZA Bone; 2019 Dec; 129():115058. PubMed ID: 31493530 [TBL] [Abstract][Full Text] [Related]
51. Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population. Rojas-Campos E; Ruvalcaba-Contreras N; Campos-Mariz A; Aguilar-Campos A; Andrade-Sierra J; Cerrillos-Gutiérrez JI; Medina-Pérez M; Evangelista-Carrillo L; Banda A; Cueto-Manzano AM Arch Med Res; 2024 Jun; 55(4):103008. PubMed ID: 38824883 [TBL] [Abstract][Full Text] [Related]
52. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience. Liangos O; Kirchhoff S; Buchholz J; Ketteler M Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519 [TBL] [Abstract][Full Text] [Related]
53. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764 [TBL] [Abstract][Full Text] [Related]
54. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce. Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859 [TBL] [Abstract][Full Text] [Related]
55. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment. Martín-Vírgala J; Fernández-Villabrille S; Martín-Carro B; Tamargo-Gómez I; Navarro-González JF; Mora-Fernández C; Calleros L; Astudillo-Cortés E; Avello-Llano N; Mariño G; Dusso AS; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986200 [TBL] [Abstract][Full Text] [Related]
56. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder. Chauhan V; Kelepouris E; Chauhan N; Vaid M South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328 [TBL] [Abstract][Full Text] [Related]
57. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Souqiyyeh MZ; Shaheen FA Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700 [TBL] [Abstract][Full Text] [Related]
58. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update]. Okuno S Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933 [TBL] [Abstract][Full Text] [Related]
59. A new approach for evaluating bone turnover in chronic kidney disease. Tolouian R; Hernandez GT; Chiang WY; Gupta A Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428 [TBL] [Abstract][Full Text] [Related]
60. Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease. Sonkar SK; Bhutani M; Sonkar GK; Pandey SK; Chandra S; Bhosale V Saudi J Kidney Dis Transpl; 2017; 28(4):758-763. PubMed ID: 28748877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]